Who is sponsoring NCT07503067?

NCT07503067 is sponsored by Mclean Hospital.

What drugs are being tested in NCT07503067?

Interventions in NCT07503067: none, there is no intervention in this study.

What condition does NCT07503067 study?

NCT07503067 studies Substance Use Disorder (SUD).

Is NCT07503067 still recruiting?

NCT07503067 is currently recruiting now. Last updated 31 March 2026.

Last reviewed 2026-03-31 · How we verify

NCT07503067

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Identifying Substance Use Consequences

Recruiting now Last updated 31 March 2026

What this trial tests

trial testing none, there is no intervention in this study in Substance Use Disorder (SUD) in 50 participants. Currently enrolling.

Timeline

10 February 2026

Primary endpoint
30 June 2027

31 July 2027

Quick facts

Lead sponsor	Mclean Hospital
Status	Recruiting now
Study type	OBSERVATIONAL
Enrollment	50
Start date	10 February 2026
Primary completion	30 June 2027
Estimated completion	31 July 2027
Sites	1 location across United States

Drugs / interventions tested

none, there is no intervention in this study

Conditions studied

Substance Use Disorder (SUD) — all drugs for Substance Use Disorder (SUD) →

Sponsor

Mclean Hospital

Who can join

18 and older, any sex, with Substance Use Disorder (SUD). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this study is to develop a new tool for measuring substance use disorder treatment outcome. We will start by interviewing people and gathering advisory groups to develop the items for this new tool.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Substance Use Disorder (SUD)

Currently open trials in the same condition.

NCT07278427 — Reducing Parental Substance Use and Enhancing Family Resilience Among Rural Families Through Ohio START · recruiting
NCT06790641 — Pathways to Perinatal Mental Health Equity · NA · recruiting
NCT07433985 — California MEPS Hub · NA · recruiting
NCT07214467 — Individualized Adaptive Deep Brain Stimulation in Opioid Use Disorder · NA · recruiting
NCT06794983 — Calls and Coordination for Transitions of Care at Re-entry · NA · recruiting

Other Mclean Hospital trials

Trials by the same sponsor.

NCT07519759 — Recovery Inspired Support Engagement (RISE) Pilot · NA · not yet recruiting
NCT07503093 — Pilot Study of Sensor-Informed Smartphone-based Mental Health Interventions for Mood in Early Psychosis · NA · not yet recruiting
NCT06816329 — Stress Dynamics and Familial Risk for Depression in Female Adolescents · NA · recruiting
NCT06876129 — Pharmacologic Augmentation of TMS for Depression With D-serine · Phase 1 · recruiting
NCT05232032 — Pharmaco-Neuroimaging Studies of Approach/Avoidance Behaviors and Post-Mortem Studies: Pharmacological Manipulation · Phase 2 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07503067 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Mclean Hospital
Last refreshed: 31 March 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07503067.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing